Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2025-12-26 @ 10:52 AM
Study NCT ID:
NCT00602459
Status:
COMPLETED
Last Update Posted:
2023-05-22
First Post:
2008-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-15
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-23
First Submit QC Date:
None
Study First Post Date:
2008-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-19
Results First Submit QC Date:
None
Results First Post Date:
2017-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-26
Last Update Post Date:
2023-05-22
Last Update Post Date Type:
ACTUAL